Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma

BACKGROUND: Alpha-l-fucosidase (AFU) not only detects hepatocellular carcinoma (HCC) early but also is used as a clinical prognostic indicator of several malignant tumors. However, no study has investigated the prognostic significance of AFU in a cohort of patients with esophageal squamous cell carc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Thorac Dis
Autori principali: Yu, Xiangyang, Zhang, Rusi, Yang, Tianzhen, Zhang, Mengqi, Xi, Kexing, Lin, Yongbin, Wen, Yingsheng, Wang, Gongming, Huang, Zirui, Zhang, Xuewen, Zhang, Lanjun
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790429/
https://ncbi.nlm.nih.gov/pubmed/31656672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.08.92
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi